US Stock MarketDetailed Quotes

PTIXW PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM)

Watchlist
  • 0.0398
  • +0.0098+32.67%
Close Mar 27 16:00 ET
0Market Cap0.00P/E (TTM)

PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
54.94%1.43M
79.64%1.14M
-44.88%739.29K
-14.07%3.56M
-23.85%655.78K
20.92%924.06K
-51.36%636.67K
11.20%1.34M
62.27%4.14M
60.41%861.22K
Selling and administrative expenses
-27.21%307.68K
-35.45%307.36K
-41.73%391.26K
-34.46%1.97M
-44.27%398.26K
-16.61%422.69K
-59.24%476.16K
9.38%671.44K
62.20%3M
44.43%714.65K
-General and administrative expense
-27.21%307.68K
-35.45%307.36K
-41.73%391.26K
-34.46%1.97M
-44.27%398.26K
-16.61%422.69K
-59.24%476.16K
9.38%671.44K
62.20%3M
44.43%714.65K
Research and development costs
124.19%1.12M
421.06%836.38K
-48.04%348.03K
39.80%1.59M
75.70%257.52K
94.87%501.37K
14.17%160.52K
13.08%669.84K
62.45%1.14M
248.47%146.57K
Operating profit
-54.94%-1.43M
-79.64%-1.14M
44.88%-739.29K
14.07%-3.56M
23.85%-655.78K
-20.92%-924.06K
51.36%-636.67K
-11.20%-1.34M
-62.27%-4.14M
-60.41%-861.22K
Net non-operating interest income expense
253.55%37.26K
881.20%53.1K
261.43%25.63K
110.42%48.33K
326.63%60.47K
109.23%10.54K
97.16%-6.8K
81.08%-15.88K
-88.75%-463.71K
71.44%-26.68K
Non-operating interest income
62.88%69.22K
157.47%84.71K
216.65%56.89K
459.49%185.79K
183.18%92.43K
12,547.62%42.5K
14,393.39%32.9K
359,240.00%17.97K
6,514.94%33.21K
407,887.50%32.64K
Non-operating interest expense
0.00%31.96K
-20.37%31.61K
-7.63%31.26K
-72.34%137.46K
-46.13%31.96K
-72.08%31.96K
-83.40%39.7K
-59.68%33.84K
101.85%496.91K
-36.50%59.32K
Other net income (expense)
81.54%-2.18K
-411.69%-118.95K
10.57%-4.43K
-156.72%-46.05K
-143.97%-6.07K
-11.78K
-23.25K
-105.92%-4.96K
-67.34%81.18K
-102.33%-2.49K
Gain on sale of security
-96.66%-23.18K
-411.69%-118.95K
10.57%-4.43K
-156.72%-46.05K
-143.97%-6.07K
---11.78K
---23.25K
-105.92%-4.96K
-67.34%81.18K
-102.33%-2.49K
Other non- operating income (expenses)
--21K
----
----
----
----
----
----
----
----
----
Income before tax
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
-12.90%-1.36M
-77.46%-4.52M
-70.03%-890.39K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
-12.90%-1.36M
-77.46%-4.52M
-70.03%-890.39K
Net income continuous Operations
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
-12.90%-1.36M
-77.46%-4.52M
-70.03%-890.39K
Minority interest income
Net income attributable to the parent company
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
-12.90%-1.36M
-77.46%-4.52M
-70.03%-890.39K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
-12.90%-1.36M
-77.46%-4.52M
-70.03%-890.39K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 54.94%1.43M79.64%1.14M-44.88%739.29K-14.07%3.56M-23.85%655.78K20.92%924.06K-51.36%636.67K11.20%1.34M62.27%4.14M60.41%861.22K
Selling and administrative expenses -27.21%307.68K-35.45%307.36K-41.73%391.26K-34.46%1.97M-44.27%398.26K-16.61%422.69K-59.24%476.16K9.38%671.44K62.20%3M44.43%714.65K
-General and administrative expense -27.21%307.68K-35.45%307.36K-41.73%391.26K-34.46%1.97M-44.27%398.26K-16.61%422.69K-59.24%476.16K9.38%671.44K62.20%3M44.43%714.65K
Research and development costs 124.19%1.12M421.06%836.38K-48.04%348.03K39.80%1.59M75.70%257.52K94.87%501.37K14.17%160.52K13.08%669.84K62.45%1.14M248.47%146.57K
Operating profit -54.94%-1.43M-79.64%-1.14M44.88%-739.29K14.07%-3.56M23.85%-655.78K-20.92%-924.06K51.36%-636.67K-11.20%-1.34M-62.27%-4.14M-60.41%-861.22K
Net non-operating interest income expense 253.55%37.26K881.20%53.1K261.43%25.63K110.42%48.33K326.63%60.47K109.23%10.54K97.16%-6.8K81.08%-15.88K-88.75%-463.71K71.44%-26.68K
Non-operating interest income 62.88%69.22K157.47%84.71K216.65%56.89K459.49%185.79K183.18%92.43K12,547.62%42.5K14,393.39%32.9K359,240.00%17.97K6,514.94%33.21K407,887.50%32.64K
Non-operating interest expense 0.00%31.96K-20.37%31.61K-7.63%31.26K-72.34%137.46K-46.13%31.96K-72.08%31.96K-83.40%39.7K-59.68%33.84K101.85%496.91K-36.50%59.32K
Other net income (expense) 81.54%-2.18K-411.69%-118.95K10.57%-4.43K-156.72%-46.05K-143.97%-6.07K-11.78K-23.25K-105.92%-4.96K-67.34%81.18K-102.33%-2.49K
Gain on sale of security -96.66%-23.18K-411.69%-118.95K10.57%-4.43K-156.72%-46.05K-143.97%-6.07K---11.78K---23.25K-105.92%-4.96K-67.34%81.18K-102.33%-2.49K
Other non- operating income (expenses) --21K------------------------------------
Income before tax -50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K-12.90%-1.36M-77.46%-4.52M-70.03%-890.39K
Income tax 0000000000
Net income -50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K-12.90%-1.36M-77.46%-4.52M-70.03%-890.39K
Net income continuous Operations -50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K-12.90%-1.36M-77.46%-4.52M-70.03%-890.39K
Minority interest income
Net income attributable to the parent company -50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K-12.90%-1.36M-77.46%-4.52M-70.03%-890.39K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K-12.90%-1.36M-77.46%-4.52M-70.03%-890.39K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg